Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 21 - 40 of 51
  • «
  • 1
  • 2
  • 3
  • »
Poor access to care among AYA patients is not only evident in low clinical trial enrollment. The struggle to access much-needed care continues when treatment concludes. Most AYA cancer survivors must learn to navigate follow-up medical care on their own.
The Road to Recovery Report makes specific recommendations for maintaining the adaptations made necessary to accommodate the disruptions caused by the pandemic. Where possible, the report recommends building on that momentum to spur much-needed change in cancer care and research.
Montana is one of the most rural states in the U.S., with nearly half of its population living in rural regions. Accordingly, accessing healthcare services can be difficult for Montana’s citizens, and gaining access to clinical trials is particularly challenging.
ACCCBuzz sat down with ASCO's Dr. Richard L. Schilsky to look back on his career and look forward to the future breakthroughs in this era and beyond.
Carla Strom, MLA, speaks with ACCCBuzz about her role as an advocate, how this role has evolved, and why listening to the community's voice early and often in clinical trial development and cancer research is vital.
Learn how the PECaD program at Siteman Cancer Center is decreasing disparities in care by monitoring data, engaging the community, supporting research, and ensuring diverse representation in research.
With the enormous pressures of COVID-19, the ever-increasing complexity of oncology care, and the persistent social factors that lead to medical injustice, it is difficult to think about tackling even one more job. Yet, we must, we can, and we do. Today I want to mention four specific areas that all cancer programs need to be watching, thinking about, and preparing for.
This is the story of how a large independent practice in northwest Arkansas has nurtured its research program over several decades and is now able to offer patients access to phase I, II, and III trials close to home and their families.
In this article, we describe patients’ perspectives on participation in CCDR studies based on feedback and comments received from patients during our research. Insights reveal the importance and enthusiasm for CCDR studies expressed by patients, and their perspectives on these studies will inform future research and clinical practice toward high quality, patient-centered care delivery.
In the final installment of ACCC’s webinar series honoring American Pharmacists Month, experts discussed the integral role pharmacists play in supporting clinical trial research in the community setting, and they identified opportunities for extending the pharmacist role in an increasingly complex research landscape.
At the risk of repeating a phrase that has been exhausted this year, the dawn of 2020 brought with it unprecedented times. Whereas a pandemic on its own would have dominated everything else, this year also brought on an economic depression; a racial awakening; record-breaking wildfires, hurricanes, and floods; political turmoil on an extraordinary scale; and a host of additional unique phenomena. …
With more than 25 years of oncology nursing experience and more than 18 years as an oncology nurse practitioner, Christa Braun-Inglis, MS, APRN-Rx, FNP-BC, AOCNP, has a wealth of clinical expertise.
"I see the liver cancer heatmap being used as a source of networking between institutions and as a way to help patients find a medical facility to help navigate their care closer to home."
Listed are my highlights of the ASCO 2020 abstracts, which were chosen if they were a practice-changing study or trial with important new advances.
Evidence-based diet and exercise interventions and programs that can improve cancer survivors’ quality of life and physical and mental health.
Improving patient access to clinical trials has long been a vexing issue for clinicians and patient advocates. Although trials are the backbone of cancer research, participation rates have remained unchanged in recent decades. As a result, more attention is being paid to the lack of diversity in clinical trial populations. The National Coalition for Cancer Survivorship (NCCS) held its 2019 Cancer Policy …
ACCC 36th National Oncology Conference featured speaker author and journalist Mary Elizabeth Williams held the packed room rapt with the story of her patient experience. She was diagnosed and treated for stage II melanoma in 2010. One year later, the cancer returned. This time the melanoma was stage IV. At that time, patients with stage IV melanoma had about a five percent chance of surviving five …
The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute’s Cancer and Aging Resilience (CARE) Clinic goes beyond reviewing cancer-specific treatment. This new care model pairs patients with a multidisciplinary team to assess patients for balance, cognition, nutrition, symptom management, and many more—all in one visit.
The amazing advances seen in cancer care are the result of successful completion of clinical trials. But the fact is that we could do so much better.
In Louisiana, cancer incidence and death rates are greater than the national average. However, access to early phase clinical trials was nearly impossible to find. 2018 ACCC Innovator Award winner Ochsner Health System partnered with the Translational Genomics Research institute to establish a dedicated center to that accelerated treatment development and expanded patient access to precision …
    Displaying results 21 - 40 of 51
  • «
  • 1
  • 2
  • 3
  • »